MOVE
Movano, Inc.
NASDAQ · Healthcare · Medical - Devices · US
$8.20
+2.37%Year over year
Reported trailing growth
- Revenue
- +843.6%
- EBITDA
- -13.9%
- EBIT
- -31.6%
- EPS
- —
- Free cash flow
- -12.9%
- Operating cash flow
- +23.8%
Forward estimates
Based on analyst estimates
- Revenue
- +2131.1%
- EBITDA
- +153.9%
- EPS
- +94.5%
Three-year CAGR
- Revenue
- -57.3%
- EBITDA
- +35.6%
- EBIT
- +36.0%
- Net income
- +22.9%
- EPS
- +30.8%
- Free cash flow
- +50.0%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Jun 1, 2026